What is the recommended maximum intravenous paracetamol dose for children, including per‑dose and 24‑hour limits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intravenous Paracetamol Dosing in Children

For children, intravenous paracetamol should be dosed at 15 mg/kg per dose (maximum 1000 mg per dose) every 6 hours, with a maximum daily dose of 60 mg/kg/day or 4000 mg/day, whichever is less. 1

Weight-Based Dosing by Age Groups

Term Neonates and Infants (Birth to <10 kg)

  • Per-dose: 7.5 mg/kg every 6 hours 1
  • Maximum daily dose: 30 mg/kg/day 1
  • This lower dosing reflects reduced clearance in neonates, which reaches only 84% of mature values by 1 year of age 2

Children 10-33 kg (Approximately 1-12 Years)

  • Per-dose: 15 mg/kg every 6 hours (maximum 1000 mg per dose) 1
  • Maximum daily dose: 60 mg/kg/day or 4000 mg/day, whichever is less 1

Adolescents and Children >33 kg (≥12 Years)

  • Per-dose: 1000 mg every 6 hours 1
  • Maximum daily dose: 4000 mg/day 1

Critical Dosing Considerations

Preterm Neonates (Special Populations)

For preterm neonates, dosing must be adjusted based on post-conceptual age (PCA) due to significantly reduced clearance 3:

  • 27-28 weeks PCA: Loading dose 40 mg/kg, then 20 mg/kg every 6 hours 3
  • 32 weeks PCA: Loading dose 40 mg/kg, then 25 mg/kg every 6 hours 3
  • 36 weeks PCA: Loading dose 40 mg/kg, then 30 mg/kg every 6 hours 3
  • Clearance increases from 2.85 L/h/70 kg at 27 weeks PCA to 7.05 L/h/70 kg by 42 weeks 3

High-Risk Populations Requiring Dose Reduction

Caution and potential dose reduction are warranted in: 4

  • Children with pre-existing malnutrition (increased hepatotoxicity risk) 4
  • Obese children (altered pharmacokinetics) 4
  • Neuromuscular disorders (increased hepatotoxicity risk) 4
  • Renal impairment (requires dose adjustment) 5

Absolute Contraindications for Standard Dosing

Do not use standard IV paracetamol dosing in: 4

  • Dehydrated children (use NSAIDs contraindicated; paracetamol preferred but monitor closely) 4
  • Active renal impairment (dose reduction required) 4

Administration Guidelines

Infusion Parameters

  • Infusion time: 15 minutes for all doses 3
  • Minimum interval between doses: 4 hours (though 6-hour intervals are standard) 1
  • Doses can be administered with or without meals when transitioning to oral formulations 6

Monitoring Requirements

  • Discontinue and contact physician if symptoms do not improve after dosing 6
  • Seek medical evaluation if fever persists >3 days despite treatment 6
  • Monitor for new symptoms developing during treatment 6

Common Pitfalls to Avoid

  1. Exceeding daily maximum: The 24-hour maximum is critical—60 mg/kg/day in children or 4000 mg/day in adolescents/adults, whichever is less 1

  2. Inadequate dosing in neonates: Using adult weight-based dosing (15 mg/kg) in neonates results in excessive exposure due to immature clearance; use 7.5 mg/kg instead 1

  3. Ignoring post-conceptual age in preterm infants: Clearance varies dramatically with PCA, requiring individualized dosing schedules 3

  4. Overlooking concurrent paracetamol-containing medications: Always verify total daily paracetamol intake from all sources to prevent exceeding maximum daily dose 7

  5. Using in high-risk populations without adjustment: Children with malnutrition, obesity, or neuromuscular disorders require careful risk-benefit assessment and potentially reduced dosing 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.